HbA1c overestimates the glucose management indicator: a pilot study in patients with diabetes, chronic kidney disease not on dialysis, and anemia using isCGM.

Ana María Gómez MedinaCamilo A GonzálezOscar M MuñozYalinne GómezPablo E JaramilloDiana HenaoLuis M RodríguezYurany Molina

Published in: Therapeutic advances in endocrinology and metabolism (2024)

The HbA1c overestimates the GMI values with highly variable ranges of difference, which prevents a precise correction factor. isCGM probably is a safer option for monitoring and decision-making in this population, especially in patients treated with insulin where the risk of hypoglycemia is greater.

Keyphrases

chronic kidney disease
end stage renal disease
type diabetes
glycemic control
blood glucose
peritoneal dialysis
insulin resistance
metabolic syndrome
blood pressure
weight loss
iron deficiency